The review's conclusions suggested that isoflavone mixtures are not effective in decreasing bone loss in perimenopausal and postmenopausal Western women. Limitations relating to searches, the statistical analyses, and the reporting of study quality means the authors' conclusions should be interpreted with caution.
To evaluate the effectiveness of phytoestrogens on bone mineral density in menopausal Western women.
Searching
MEDLINE and EMBASE were searched from 1990 to February 2010 for studies published in English; search terms were reported. Reference lists of selected articles and reviews were examined.
Study selection
Parallel-group randomised controlled trials (RCTs) of soy products (containing soy isoflavone) taken for at least three months by Western perimenopausal or postmenopausal women and that reported bone mineral density as an index of bone mass were eligible for inclusion. Comparator groups could not take phytoestrogens. Studies with main outcome measures that were markers of bone turnover were excluded.
All studies except one were of postmenopausal women. Isoflavone doses (administered in various ways) ranged from 52 to 120mg/day of aglycone equivalents. All trials were placebo controlled. Most trials were conducted in USA. Treatment duration ranged from 24 weeks to three years.
Two reviewers independently selected studies. Disagreements were resolved by a third reviewer.
Assessment of study quality
Study quality was evaluated independently by two reviewers who assessed selection bias, performance bias and attrition bias.
Data extraction
Data were extracted in order to calculate mean differences (MD) with 95% confidence intervals (CI). Authors were contacted for missing data when necessary.
Two reviewers independently extracted data.
Methods of synthesis
Studies that reported pre-and post-treatment (or change from baseline) lumbar spine bone mineral density as an outcome were eligible for meta-analysis using a fixed-effect model (or random effects when significant heterogeneity was found). Heterogeneity was assessed with Χ². Five pre-specified subgroup analyses were reported. A funnel plot was used to detect publication bias. A narrative synthesis was also performed.
Results of the review
Seventeen RCTs were included (2,042 completers, range 16 to 362). The authors reported that all 12 trials (n=1,433) included in the meta-analyses were properly randomised and double-blinded with biases unlikely to occur. They also reported that attrition bias appeared to be an issue with a high proportion of participants who stopped treatment (and placebo) . No further details relating to study quality were reported.
Seven of the 17 RCTs found bone-sparing effects with isoflavones, but meta-analysis indicated lumbar spine bone mineral density was not significantly different from placebo (MD 9.86mg/cm², 95% CI -2.64 to 22.36 mg/cm²; 12
